Organization Overview
Historical Acquisition Tree
Alternative names
angiotensin ii (2017 NDA)
Autoimmune Diseases (Phase 3)
beta-Thalassemia (Phase 2)
Glomerulonephritis (Phase 3)
Hemochromatosis (Phase 2)
Hepatorenal Syndrome (Phase 1)
Hypotension (Phase 4)
Immune System Diseases (Phase 3)
Iron Overload (Phase 2)
Kidney Diseases (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lupus Erythematosus, Systemic (Phase 3)
Lupus Nephritis (Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Multiple Myeloma (Phase 1)
Neoplasms, Plasma Cell (Phase 1)
Nephritis (Phase 3)
Renal Insufficiency, Chronic (Phase 2)
Shock (Phase 4)
Shock, Surgical (Phase 4)
Syndrome (Phase 1)
Thalassemia (Phase 2)